Testosterone Does Not Increase Penis Size in Adult Men
Testosterone therapy will not increase penile length in adult males, regardless of hypogonadism status, because penile growth is dependent on androgen exposure during critical developmental periods (infancy, childhood, and puberty) when growth plates remain open—not in adulthood. 1, 2
Why Testosterone Cannot Increase Adult Penile Length
Developmental Window for Penile Growth
Androgens are responsible for penile growth and maturation during specific developmental periods only. The FDA label explicitly states that testosterone effects include "growth and maturation of the prostate, seminal vesicles, penis, and scrotum" as part of normal development—not adult enlargement. 1
Penile growth occurs through androgen-dependent mechanisms during fetal development, infancy, childhood, and puberty, culminating in epiphyseal fusion. Once bone maturation is complete, the growth process terminates. 1
Studies in men with congenital hypogonadotropic hypogonadism demonstrate that testosterone treatment during childhood and puberty normalizes adult penile size (mean 10.3 cm, range 8-14 cm), but this requires intervention during developmental windows. 2
Evidence from Adult Testosterone Therapy Studies
A 2016 study specifically measuring penile length in 88 adult men (mean age 51.1 years) with late-onset hypogonadism receiving 12 months of testosterone therapy found "no significant changes in penile length were observed." 3 This is the most direct evidence addressing your question.
The same study did show improvements in erectile function, nocturnal penile tumescence frequency and duration, and blood flow in cavernous arteries—but not structural penile enlargement. 3
What Testosterone DOES Improve in Hypogonadal Adults
While testosterone cannot increase penile size in adults, it provides other benefits for men with confirmed hypogonadism:
Sexual function improvements: Testosterone therapy enhances erectile function, particularly when combined with PDE5 inhibitors in men who previously failed sildenafil monotherapy. 4
Quality of life benefits: The American College of Physicians guidelines note that testosterone may provide "small improvements in sexual functioning and quality of life" in older men with low testosterone. 5
Symptom relief: The European Association of Urology identifies specific hypogonadal symptoms including reduced sexual intercourse frequency, decreased energy, and reduced physical strength that may respond to therapy. 5
Clinical Approach to the Concerned Patient
Diagnostic Requirements Before Considering Therapy
Diagnosis of hypogonadism requires BOTH persistent specific symptoms AND confirmed testosterone deficiency through biochemical testing with morning total testosterone levels measured on at least 2 occasions. 5
FDA-approved indications for testosterone are limited to replacement therapy in men with primary or secondary hypogonadism caused by disorders of the hypothalamus, pituitary gland, or testes—not for penile enlargement or cosmetic purposes. 1
Critical Counseling Points
If the primary concern is penile size rather than hypogonadal symptoms, testosterone therapy is not indicated and will not achieve the desired outcome. 3
Approximately 20% of men initiating testosterone therapy in the U.S. have testosterone levels above 300 ng/dL (10.41 nmol/L), suggesting inappropriate prescribing. 5
Testosterone therapy carries risks including suppression of spermatogenesis, polycythemia, and potential cardiovascular concerns, making it inappropriate for non-indicated use. 1
When Penile Size IS Responsive to Androgens
The only clinical scenario where androgens increase penile length involves prepubertal treatment of micropenis due to congenital testosterone deficiency:
Boys with micropenis secondary to fetal testosterone deficiency who receive 1-2 short courses of testosterone in infancy/childhood achieve normal adult penile size (within 2 SD of mean). 2
Prepubertal androgen exposure does NOT compromise adult penile length, contrary to animal models. 6
This window closes after puberty when epiphyseal fusion occurs. 1, 2
Common Pitfall to Avoid
Do not prescribe testosterone therapy for penile size concerns in adult men. This represents off-label use without efficacy data, exposes patients to unnecessary risks, and may reflect underlying body dysmorphic concerns requiring different management. 5, 1, 3